Page last updated: 2024-09-04

carbapenems and fosfomycin

carbapenems has been researched along with fosfomycin in 62 studies

Compound Research Comparison

Studies (carbapenems)	Trials (carbapenems)	Recent Studies (post-2010) (carbapenems)	Studies (fosfomycin)	Trials (fosfomycin)	Recent Studies (post-2010) (fosfomycin)
7,355	147	5,277	2,335	181	1,022

Protein Interaction Comparison

Protein	Taxonomy	carbapenems (IC50)	fosfomycin (IC50)
UDP-N-acetylglucosamine 1-carboxyvinyltransferase	Escherichia coli K-12		3.5795

Research

Studies (62)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (1.61)	29.6817
2010's	35 (56.45)	24.3611
2020's	26 (41.94)	2.80

Authors

Authors	Studies
Chalevelakis, G; Damala, M; Falagas, ME; Michalopoulos, A; Rafailidis, P; Virtzili, S	1
Giamarellou, H; Poulakou, G	1
Kiratisin, P; Leelaporn, A; Leelarasmee, A; Netikul, T	1
Apisarnthanarak, A; Mundy, LM	2
Arda, B; Pullukcu, H; Senol, S; Sipahi, H; Sipahi, OR; Tasbakan, M; Ulusoy, S; Yamazhan, T	1
Ahmed-Bentley, J; Peirano, G; Pitout, JD; Woodford, N	1
Chayakul, P; Garey, KW; Pattharachayakul, S; Santimaleeworagun, W; Tansakul, P; Wongpoowarak, P	1
Hall, GS; Neuner, EA; Sekeres, J; van Duin, D	1
Bachmann, A; Bonkat, G; Braissant, O; Frei, R; Gasser, TC; Müller, G; Rieken, M; Tschudin-Suter, S; Widmer, AF; Wyler, S	1
Giannella, M; Lewis, R; Petrosillo, N; Viale, P	1
Hernández, E; Picazo, JJ; Rodríguez-Avial, C; Rodríguez-Avial, I	1
Burgmann, H; Lingscheid, T; Mitteregger, D; Poeppl, W; Tobudic, S	1
Abreu-Lanfranco, O; Bheemreddy, S; Dhar, S; Hayakawa, K; Kaye, KS; Lephart, PR; Marchaim, D; Martin, ET; Mynatt, RP; Pogue, JM; Sunkara, B; Zhao, JJ	1
Colon-Urban, R; Kopacz, J; Mariano, N; Segal-Maurer, S; Sychangco, P; Urban, C; Wehbeh, W	1
Anders, A; Gatermann, SG; Kaase, M; Szabados, F	1
Feng, X; Fu, Y; Li, Y; Liu, HM; Qi, H; Qin, S; Rong, L; Shan, L; Tian, H; Wen, JG; Xu, H; Xu, L; Yu, Y; Zeng, L; Zhang, Q	1
Sirijatuphat, R; Thamlikitkul, V	1
Abbasi, SA; Day, KM; Paterson, DL; Perry, JD; Raza, MW; Sartor, AL; Sidjabat, HE	1
Chomnawang, MT; Khuntayaporn, P; Kunakonvichaya, B; Montakantikul, P; Thirapanmethee, K	1
Cai, Y; Di, X; Liang, B; Liu, B; Liu, Y; Ni, W; Wang, J; Wang, R; Zhang, X	1
Amaya-Villar, R; Díaz-Martín, A; Ferrándiz-Millón, C; Garnacho-Montero, J; Gutiérrez-Pizarraya, A; López-Sánchez, JM	1
Gil-Romero, Y; Gómez-Garcés, JL; Muñoz-Paraíso, C; Regodón-Domínguez, M; Sanz-Rodríguez, N	1
Asuphon, O; Houngsaitong, J; Kiratisin, P; Montakantikul, P; Sonthisombat, P	1
Al-Abri, SS; Al-Jardani, A; Aldeesi, Z; Carattoli, A; Darwish, D; Ghazawi, A; Hashmey, R; Jamal, W; Pál, T; Rotimi, V; Sonnevend, Á; Villa, L	1
Carrilho, C; Costa, SF; Guimaraes, T; Levin, AS; Marchi, AP; Miranda, L; Rizek, C; Rosa, JF	1
Hu, YY; Huang, L; Zhang, R	1
Abbo, LM; Aragon, L; Bonomo, RA; Camargo, JF; Hujer, AM; Martinez, O; Nicolau, DP; Perez, F; Perez-Cardona, A; Rojas, LJ; Rosa, R; Rudin, SD; Tekin, A	1
Abbo, LM; Bonomo, RA; Camargo, JF; Hujer, AM; Martinez, O; Perez, F; Perez-Cardona, A; Rojas, LJ; Rosa, R; Rudin, SD	1
Chatsuwan, T; Singkham-In, U	1
Cao, Y; He, L; Hu, F; Wang, A; Wang, C; Yin, D; Zhang, L	1
Chakraborty, T; Fritzenwanker, M; Herold, S; Imirzalioglu, C; Wagenlehner, FM; Zimmer, KP	1
Bodmann, KF	1
Avery, LM; Nicolau, DP; Sutherland, CA	1
Dewar, JB; Ekwanzala, MD; Kamika, I; Momba, MNB	1
Link, I; Loose, M; Naber, KG; Wagenlehner, FME	1
Akinci, E; Baran, I; Bodur, H; Mumcuoglu, I; Sertcelik, A	1
Ahn, JY; Choi, H; Choi, JY; Choi, YH; Jeong, SJ; Kim, JM; Ku, NS; Lee, SH; Lim, YS; Shin, SJ; Song, YG; Yeom, JS; Yong, D	1
Chen, S; Li, XY; Liu, CX; Liu, P; Qi, M; Wu, ZY	1
Carone, G; Dalfino, L; De Robertis, A; Del Prete, R; Mosca, A; Romanelli, F; Stufano, M	1
Cao, J; Dhanasekaran, V; Fang, R; Li, J; Lithgow, T; Liu, H; Perlaza-Jiménez, L; Tian, X; Wang, C; Wang, Q; Zhao, Y; Zheng, X; Zhou, T	1
Ayfan, AK; Mohd Sazlly Lim, S; Naicker, S; Roberts, JA; Sime, FB; Zowawi, H	1
Ashraf, T; Barathan, G; Darwish, D; Ghazawi, A; Hashmey, R; Pál, T; Rizvi, TA; Sonnevend, Á	1
Deemer, K; Fronczek, C; Grey, J; Marr, K	1
Chusri, S; Ontong, JC; Ozioma, NF; Voravuthikunchai, SP	1
Bragantini, D; Carrara, E; Cattaneo, P; Chiamenti, M; Ellis, S; Franceschi, F; Giske, CG; Lodise, T; Menchinelli, G; Piddock, LJV; Righi, E; Sanguinetti, M; Savoldi, A; Scudeller, L; Tacconelli, E	1
Akalın, H; Eser, ÖK; Gürpınar, Ö; Köksal, İ; Otlu, B; Özakın, C; Ünal, S; Zarakolu, P	1
Ambretti, S; Antonelli, A; Bartoletti, M; Bassetti, M; Bussini, L; Cavallo, R; Coppi, M; Corcione, S; De Rosa, FG; Dettori, S; Gaibani, P; Giacobbe, DR; Giani, T; Giannella, M; Lewis, R; Marchese, A; Marconi, L; Pascale, R; Rossolini, GM; Shbaklo, N; Viale, P	1
Chen, L; Chen, T; Fang, R; Liao, W; Xu, C; Zhang, S; Zhou, C; Zhou, T	1
Courtois, R; Danneels, P; Dubée, V; Eveillard, M; Kempf, M; Mahieu, R; Quinqueneau, C; Rihet, C; Vannier, C	1
Li, M; Liu, Y; Ma, W; Sun, L; Sun, S; Wu, J; Zhao, W	1
Guery, B; Jacot, D; Papadimitriou-Olivgeris, M	1
Aysert-Yildiz, P; Dizbay, M; Habibi, H; Özgen-Top, Ö	1
Crudele, V; De Filippis, A; Della Rocca, MT; Finamore, E; Foglia, F; Franci, G; Galdiero, M; Greco, G	1
Afridi, FI; Baig, S; Jamal, Q; Khan, R; Sani, AI; Zaidi, SAA	1
Borrazzo, C; Bruni, A; Garofalo, E; Gullì, S; Lionello, R; Longhini, F; Marascio, N; Matera, G; Quirino, A; Romeo, F; Russo, A; Serapide, F; Serraino, R; Torti, C; Trecarichi, EM	1
Adaleti, R; Aksaray, S; Arıcı, N; Çalık, Ş; Kansak, N; Nakipoğlu, Y; Şenbayrak, S	1
Fukasawa, T; Kawakami, K; Okura, T; Takahashi, H; Urushihara, H	1
Birinci, A; Ertokatlı, M; Güney, DB; Hacıeminoğlu Ülker, K; Karacan Temür, G; Tanrıverdi Çaycı, Y	1
Aygen, B; Bolat, D; Dinc, G; Eren, EE; Gönen, ZB; İzci, F; Ture, Z; Ünüvar, GK; Yay, AH; Yıldız, O	1
Akalın, H; Girgin, NK; İşçimen, R; Kahveci, FŞ; Kaya, PK; Önal, U; Özakın, C; Tüzemen, NÜ	1
Baum, K; Bonomo, RA; Doi, Y; Evans, SR; Fowler, VG; Hamasaki, T; Komarow, L; Lodise, TP; Patel, R; Rodvold, KA; Rouphael, N; Satlin, MJ; Schwager, N; Souli, M; Tamma, PD; van Duin, D; Van Tyne, D	1

Reviews

5 review(s) available for carbapenems and fosfomycin

Article	Year
Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs, 2009, Oct-01, Volume: 69, Issue:14 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline	2009
Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art. Expert review of anti-infective therapy, 2013, Volume: 11, Issue:2 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Minocycline; Rifampin; Risk Factors; Tigecycline	2013
Optimum treatment strategies for carbapenem-resistant Acinetobacter baumannii bacteremia. Expert review of anti-infective therapy, 2015, Volume: 13, Issue:6 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Colistin; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Minocycline; Polymyxins; Sulbactam; Tigecycline	2015
Treatment Options for Carbapenem- Resistant Gram-Negative Infections. Deutsches Arzteblatt international, 2018, 05-21, Volume: 115, Issue:20-21 Topics: Aminoglycosides; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Therapy, Combination; Escherichia coli; Fluoroquinolones; Fosfomycin; Germany; Gram-Negative Bacteria; Humans; Klebsiella pneumoniae; Piperacillin; Pseudomonas aeruginosa; Tigecycline	2018
Systematic review and meta-analysis of in vitro efficacy of antibiotic combination therapy against carbapenem-resistant Gram-negative bacilli. International journal of antimicrobial agents, 2021, Volume: 57, Issue:5 Topics: Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymyxins; Rifampin; Tazobactam; Tobramycin	2021

Trials

2 trial(s) available for carbapenems and fosfomycin

Article	Year
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Fosfomycin; Humans; Infusions, Intravenous; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Treatment Outcome	2010
Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome	2014

Article

Year

Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2010, Volume: 16, Issue:2

Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Critical Illness; Cross Infection; Female; Fosfomycin; Humans; Infusions, Intravenous; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies; Treatment Outcome

2010

Preliminary study of colistin versus colistin plus fosfomycin for treatment of carbapenem-resistant Acinetobacter baumannii infections.

Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome

2014

Other Studies

55 other study(ies) available for carbapenems and fosfomycin

Article	Year
In vitro activities of fosfomycin and carbapenem combinations against carbapenem non-susceptible Escherichia coli and Klebsiella pneumoniae. International journal of antimicrobial agents, 2010, Volume: 35, Issue:6 Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fosfomycin; Hospitals; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2010
Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa	2010
Carbapenem versus fosfomycin tromethanol in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related complicated lower urinary tract infection. Journal of chemotherapy (Florence, Italy), 2010, Volume: 22, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Urinary Tract Infections; Young Adult	2010
New Delhi metallo-beta-lactamase from traveler returning to Canada. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Canada; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; India; Male; Microbial Sensitivity Tests; Prostatitis; Pyelonephritis; Travel; Urine	2011
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin. International journal of antimicrobial agents, 2012, Volume: 39, Issue:3 Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors	2012
In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases. The Southeast Asian journal of tropical medicine and public health, 2011, Volume: 42, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Colistin; Drug Therapy, Combination; Fosfomycin; Humans; Imipenem; In Vitro Techniques; Microbial Sensitivity Tests; Polymerase Chain Reaction; Thailand; Time Factors	2011
Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms. Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:11 Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Female; Fosfomycin; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Retrospective Studies; Treatment Outcome; Urinary Tract Infections	2012
Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing Escherichia coli urinary isolates. World journal of urology, 2013, Volume: 31, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Ciprofloxacin; Contraindications; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fosfomycin; Humans; Male; Middle Aged; Nitrofurantoin; Prevalence; Retrospective Studies; Treatment Failure; Treatment Outcome; Urinary Tract; Urinary Tract Infections; Young Adult	2013
[Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)]. Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Prevalence; Urinary Tract Infections; Urine	2013
In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates. Pharmacology, 2013, Volume: 91, Issue:3-4 Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests	2013
Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10. The Journal of antibiotics, 2013, Volume: 66, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Fosfomycin; Gram-Positive Bacterial Infections; Humans; Michigan; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin Resistance	2013
Identification of extended-spectrum-β-lactamase-positive Klebsiella pneumoniae urinary tract isolates harboring KPC and CTX-M β-lactamases in nonhospitalized patients. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:10 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Fosfomycin; Humans; Klebsiella pneumoniae; Minocycline; Tigecycline; Urinary Tract	2013
Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. Journal of clinical microbiology, 2014, Volume: 52, Issue:6 Topics: beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Germany; Humans; Microbial Sensitivity Tests	2014
High incidence and endemic spread of NDM-1-positive Enterobacteriaceae in Henan Province, China. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:8 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; China; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Epidemiological Monitoring; Fosfomycin; Genotype; Humans; Incidence; Multilocus Sequence Typing; Plasmids	2014
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan. Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9 Topics: Acinetobacter baumannii; Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Doripenem; Enterobacteriaceae; Fosfomycin; Humans; Meropenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pakistan; Thienamycins	2014
Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates. International journal of antimicrobial agents, 2015, Volume: 45, Issue:5 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2015
In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa. The Journal of antibiotics, 2015, Volume: 68, Issue:9 Topics: Anti-Bacterial Agents; Carbapenems; China; Colistin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections	2015
[In vitro activity of fosfomycin, alone or in combination, against clinical isolates of carbapenem resistant Pseudomonas aeruginosa]. Enfermedades infecciosas y microbiologia clinica, 2016, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Carbapenems; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2016
Optimizing intravenous fosfomycin dosing in combination with carbapenems for treatment of Pseudomonas aeruginosa infections in critically ill patients based on pharmacokinetic/pharmacodynamic (PK/PD) simulation. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2016, Volume: 50 Topics: Anti-Bacterial Agents; Carbapenems; Critical Illness; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fosfomycin; Humans; Microbial Sensitivity Tests; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thailand	2016
Characterization of NDM-7 Carbapenemase-Producing Escherichia coli Isolates in the Arabian Peninsula. Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Gene Expression; Humans; Kuwait; Microbial Sensitivity Tests; Minocycline; Multilocus Sequence Typing; Oman; Phylogeny; Plasmids; Saudi Arabia; Tigecycline; United Arab Emirates	2017
Clonality, outer-membrane proteins profile and efflux pump in KPC- producing Enterobacter sp. in Brazil. BMC microbiology, 2017, 03-17, Volume: 17, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacter; Enterobacteriaceae Infections; Female; Fosfomycin; Genes, Bacterial; Hospitals; Humans; Male; Membrane Proteins; Microbial Sensitivity Tests; Middle Aged; Minocycline; Polymerase Chain Reaction; Polymyxin B; Tigecycline; Young Adult	2017
Prevalence of fosfomycin resistance and plasmid-mediated fosfomycin-modifying enzymes among carbapenem-resistant Enterobacteriaceae in Zhejiang, China. Journal of medical microbiology, 2017, Volume: 66, Issue:9 Topics: Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Gene Transfer, Horizontal; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids	2017
Application of "Precision Medicine" Through the Molecular Characterization of Extensively Drug-Resistant Klebsiella pneumoniae in a Multivisceral Transplant Patient. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017, 08-15, Volume: 65, Issue:4 Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Female; Fosfomycin; Humans; Intestines; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Postoperative Complications; Precision Medicine	2017
"Double carbapenem" and oral fosfomycin for the treatment of complicated urinary tract infections caused by bla Transplant infectious disease : an official journal of the Transplantation Society, 2018, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Fosfomycin; Humans; Kidney Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome; Urinary Tract Infections	2018
In vitro activities of carbapenems in combination with amikacin, colistin, or fosfomycin against carbapenem-resistant Acinetobacter baumannii clinical isolates. Diagnostic microbiology and infectious disease, 2018, Volume: 91, Issue:2 Topics: Acinetobacter baumannii; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Colistin; Fosfomycin; Humans; Microbial Sensitivity Tests; Thailand	2018
Clinical and molecular epidemiologic characteristics of carbapenem-resistant Klebsiella pneumoniae infection/colonization among neonates in China. The Journal of hospital infection, 2018, Volume: 100, Issue:1 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Carrier State; China; Drug Therapy, Combination; Female; Fosfomycin; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome	2018
Oral Fosfomycin-Supplemental Information Necessary. Deutsches Arzteblatt international, 2019, 02-15, Volume: 116, Issue:7 Topics: Anti-Bacterial Agents; Carbapenems; Communicable Diseases; Fosfomycin; Humans	2019
Prevalence of in vitro synergistic antibiotic interaction between fosfomycin and nonsusceptible antimicrobials in carbapenem-resistant Pseudomonas aeruginosa. Journal of medical microbiology, 2019, Volume: 68, Issue:6 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azabicyclo Compounds; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam; Tobramycin; United States	2019
Genome sequence of carbapenem-resistant Citrobacter koseri carrying bla Journal of global antimicrobial resistance, 2020, Volume: 20 Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Citrobacter koseri; Drug Resistance, Multiple, Bacterial; Fosfomycin; Genome Size; Genome, Bacterial; High-Throughput Nucleotide Sequencing; Microbial Sensitivity Tests; Phylogeny; Plasmids; Sewage; Whole Genome Sequencing	2020
Carbapenem-Containing Combination Antibiotic Therapy against Carbapenem-Resistant Uropathogenic Antimicrobial agents and chemotherapy, 2019, 12-20, Volume: 64, Issue:1 Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Fosfomycin; Humans; Levofloxacin; Microbial Sensitivity Tests; Rifampin; Urinary Tract Infections	2019
Synergistic Activities of Colistin Combinations with Meropenem, Sulbactam, Minocycline, Disodium Fosfomycin, or Vancomycin Against Different Clones of Carbapenem-Resistant Microbial drug resistance (Larchmont, N.Y.), 2020, Volume: 26, Issue:5 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteriological Techniques; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Fosfomycin; Humans; Meropenem; Minocycline; Sulbactam; Vancomycin	2020
In vivo efficacy of combination of colistin with fosfomycin or minocycline in a mouse model of multidrug-resistant Acinetobacter baumannii pneumonia. Scientific reports, 2019, 11-20, Volume: 9, Issue:1 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Disease Models, Animal; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Fosfomycin; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Minocycline; Pneumonia; Tigecycline	2019
Mechanisms of fosfomycin resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae. Journal of global antimicrobial resistance, 2020, Volume: 22 Topics: Anti-Bacterial Agents; Carbapenems; China; Drug Resistance, Bacterial; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests	2020
In Vitro Activity of Ceftazidime/Avibactam Alone and in Combination With Fosfomycin and Carbapenems Against KPC-producing Klebsiella Pneumoniae. The new microbiologica, 2020, Volume: 43, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenems; Ceftazidime; Drug Combinations; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2020
First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling. BMC microbiology, 2020, 07-20, Volume: 20, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Virulence Factors; Whole Genome Sequencing	2020
Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections. International journal of antimicrobial agents, 2020, Volume: 56, Issue:4 Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Humans; Meropenem; Microbial Sensitivity Tests; Polymyxins; Sulbactam	2020
In vitro efficacy of ceftazidime-avibactam, aztreonam-avibactam and other rescue antibiotics against carbapenem-resistant Enterobacterales from the Arabian Peninsula. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 99 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Drug Combinations; Drug Resistance, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Middle East; Tigecycline	2020
Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum β-lactamase Escherichia coli urinary tract infection treatment. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2020, Nov-16, Volume: 77, Issue:Supplement Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cohort Studies; Escherichia coli; Escherichia coli Infections; Female; Florida; Fosfomycin; Humans; Male; Microbial Sensitivity Tests; Pharmacy Service, Hospital; Retrospective Studies; Urinary Tract Infections	2020
Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates. PloS one, 2021, Volume: 16, Issue:1 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Fluoroquinolones; Fosfomycin; Klebsiella pneumoniae; Piperacillin; Tetracyclines	2021
In-vitro activity of fosfomycin against Journal of chemotherapy (Florence, Italy), 2022, Volume: 34, Issue:4 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Clinical consequences of very major errors with semi-automated testing systems for antimicrobial susceptibility of carbapenem-resistant Enterobacterales. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:9 Topics: Agar; Aged; Anti-Bacterial Agents; Carbapenems; Colistin; Female; Fosfomycin; Gentamicins; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Tigecycline	2022
In vitro activity of imipenem-relebactam alone and in combination with fosfomycin against carbapenem-resistant gram-negative pathogens. Diagnostic microbiology and infectious disease, 2022, Volume: 103, Issue:3 Topics: Anti-Bacterial Agents; Azabicyclo Compounds; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Escherichia coli; Fosfomycin; Humans; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Cefoxitin-based combination for ESBL-producing Enterobacteriaceae endocarditis. Infectious diseases now, 2022, Volume: 52, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefoxitin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Endocarditis; Enterobacteriaceae; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Microbial Sensitivity Tests; Urinary Tract Infections	2022
Antibacterial and antibiofilm activities of fosfomycin combined with rifampin against carbapenem-resistant Pseudomonas aeruginosa. Letters in applied microbiology, 2022, Volume: 75, Issue:6 Topics: Anti-Bacterial Agents; Biofilms; Carbapenems; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin	2022
How to Manage Pseudomonas aeruginosa Infections. Advances in experimental medicine and biology, 2022, Volume: 1386 Topics: Anti-Bacterial Agents; Carbapenems; Colistin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Fosfomycin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam	2022
Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Journal of chemotherapy (Florence, Italy), 2023, Volume: 35, Issue:6 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pneumonia; Urinary Tract Infections	2023
Antimicrobial resistance changing trends of Klebsiella pneumoniae isolated over the last 5 years. The new microbiologica, 2022, Volume: 45, Issue:4 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests	2022
Increasing Frequency of New Delhi Metallo-beta-Lactamase and Klebsiella pneumoniae Carbapenemase Resistant Genes in a Set of Population of Karachi. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2023, Volume: 33, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Escherichia coli; Female; Fosfomycin; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Tigecycline	2023
Efficacy of cefiderocol- vs colistin-containing regimen for treatment of bacteraemic ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii in patients with COVID-19. International journal of antimicrobial agents, 2023, Volume: 62, Issue:1 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cefiderocol; Colistin; COVID-19; Fosfomycin; Humans; Pneumonia, Ventilator-Associated	2023
Investigation of in vitro efficacy of meropenem/polymyxin B and meropenem/fosfomycin combinations against carbapenem resistant Klebsiella pneumoniae strains. Acta microbiologica et immunologica Hungarica, 2023, Jun-16, Volume: 70, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Polymyxin B	2023
Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study. The journal of allergy and clinical immunology. In practice, 2023, Volume: 11, Issue:11 Topics: Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Cross-Over Studies; Fosfomycin; Glycopeptides; Humans; Stevens-Johnson Syndrome; Trimethoprim, Sulfamethoxazole Drug Combination	2023
[Investigation of O25b-ST131 Clone Frequency and Presence of Carbapenem and Fosfomycin Resistance Genes in Escherichia coli Isolates: First Detection of fosA3 from Escherichia coli O25bSTf131 Clone from Türkiye]. Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Clone Cells; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Fosfomycin; Humans; Microbial Sensitivity Tests	2023
The efficacy of mesenchymal stem cell treatment and colistin-fosfomycin combination on colistin-resistant Acinetobacter baumannii sepsis model. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:11 Topics: Acinetobacter baumannii; Acinetobacter Infections; Animals; Anti-Bacterial Agents; Carbapenems; Colistin; Fosfomycin; Interleukin-6; Mesenchymal Stem Cells; Mice; Microbial Sensitivity Tests; Sepsis	2023
Evaluation of the combination treatments with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae. Revista da Associacao Medica Brasileira (1992), 2023, Volume: 69, Issue:11 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Fosfomycin; Humans; Klebsiella Infections; Klebsiella pneumoniae; Pneumonia, Ventilator-Associated; Retrospective Studies; Sepsis	2023
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 10-16, Volume: 77, Issue:Suppl 4 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Leadership; Microbial Sensitivity Tests; Pseudomonas aeruginosa	2023